📚 PsyDin Research Database

← PsyDin Home

Showing 15 of 20167 papers

Nanomedicine for Depression: From Blood-Brain Barrier Delivery to Neuroimmune-Barrier-Plasticity Network Reprogramming.

Authors: Wang X, Shen L, Mo Q, Wang X, Wang B, Chen J, Teng Y, Zhang Z

International journal of nanomedicine

psychopharmacology mental health open access

Ketamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction.

Authors: Liu Y, Liu X, Olbrich S, Lao CL, Zhang H, Brunovsky M, Ip CT

Therapeutic advances in psychopharmacology

psychopharmacology mental health open access

A computational pipeline for a neurotransmitter-centric analysis of the effects of psychiatric medication on EEG spectral power.

Authors: Zekerallah SS, Maxion AA, Zweerings J, Teucher P, Mathiak K, Kutafina E, Gaebler AJ

Frontiers in psychiatry

psychopharmacology mental health open access

A self-management intervention for bipolar disorder using a WeChat mini program (Mood Calm): study protocol for intervention design, development, and a preliminary trial.

Authors: Lin X, Ba Z, Lu D, Ma R, Chen M, Zhu C, Liao Y, Yu X, Liu Y, Lin D

Frontiers in psychology

psychopharmacology mental health open access

The Theory of Metabolic Jet Lag in Bipolar Disorder: A Pilot Feasibility Study Exploring the Association Between Eating Rhythm Disruption and Illness Burden Parameters.

Authors: Koning E, Breda V, Panjeh S, Brietzke E

Bipolar disorders

psychopharmacology mental health open access

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study.

Authors: Brikell I, Astrup A, Wimberley T, Araki M, Chang Z, Demontis D, Dong Z, Faraone SV, Gao L, Gillies MB, Haavik J, Hartman C, Larsson H, Man KKC, Pearson SA, Snieder H, Vos M, Wong ICK, Yao H, Yuen AS, Zhang-James Y, Zhou Y, Zoega H, Engeland A, Dalsgaard S, Klungsøyr K

BMJ mental health

psychopharmacology mental health open access

Effectiveness of IV Ketamine Therapy in the Management of Treatment Resistant Depression.

Authors: Dogar IA, Sajid P, Fatima D, Fatima S, Zahra FT

BJPsych Open

psychopharmacology mental health open access

Prescribing Trends of Mood Stabilisers Within an Assertive Outreach Team (AOT) in York.

Authors: Elisha-Aboh C, Marson E, Riley T, Akubuiro C

BJPsych Open

psychopharmacology mental health open access

Olanzapine Use in Children and Adolescents With Anorexia Nervosa: A Narrative Synthesis of Efficacy, Safety and Applicability to UK Practice.

Authors: Nocton S, Dawson N, Stanley C

BJPsych Open

psychopharmacology mental health open access

Repurposing Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors for the Treatment of Stimulant Use Disorder.

Authors: Keen C, Ramkaran AS, Mahadeosingh N, Sahai MA

BJPsych Open

psychopharmacology mental health open access

Onset, Duration, and Incidence of Adverse Events by Dose and Titration Schedule of Xanomeline and Trospium Chloride.

Authors: Dyme R, Hoogerheyde J, Pavithran A, Tiwari R, Appio J

BJPsych Open

psychopharmacology mental health open access

Promethazine Is Increasingly, Inappropriately, Being Prescribed as a Sleep-Aid.

Authors: King J, Kumar K, Anderson K

BJPsych Open

psychopharmacology mental health open access

Results From a Phase 4, Slow-Titration and Food Effect Trial to Assess the Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia.

Authors: Hoogerheyde J, Walling D, Johnson K, Dyme R, Gaudy A

BJPsych Open

psychopharmacology mental health open access

Improving Outcomes Best Practices for Pregabalin Withdrawal Management in Hospitals.

Authors: Flynn A, Gregg B

BJPsych Open

psychopharmacology mental health open access

Expanding the Antipsychotic Arsenal: Drug Discovery for Schizophrenia via Virtual Screening and Ligand Optimization of FDA-Approved Drugs.

Authors: Goyal R, van Adrichem S

BJPsych Open

psychopharmacology mental health open access